BDBM50428092 CHEMBL32362 tetrahydro-magnolol
CHEMBL2331642 BDBM50428093 8,9-dihydroxydihydro-magnolol
- Di Micco, S; Pulvirenti, L; Bruno, I; Terracciano, S; Russo, A; Vaccaro, MC; Ruggiero, D; Muccilli, V; Cardullo, N; Tringali, C; Riccio, R; Bifulco, G Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors. Bioorg Med Chem 26: 3953-3957 (2018)
- Rempel, V; Fuchs, A; Hinz, S; Karcz, T; Lehr, M; Koetter, U; Müller, CE Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55. ACS Med Chem Lett 4: 41-5 (2013)
- Chen, L; Wu, YT; Gu, XY; Xie, LP; Fan, HJ; Tan, ZB; Zhang, WT; Chen, HM; Li, J; Huang, GQ; Liu, B; Zhou, YC; Sun, XM Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts. Bioorg Med Chem Lett 43: (2021)
- Yang, TH; Ma, YB; Geng, CA; Yan, DX; Huang, XY; Li, TZ; Zhang, XM; Chen, JJ Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression. Eur J Med Chem 156: 381-393 (2018)
- Chu, J; Yang, R; Cheng, W; Cui, L; Pan, H; Liu, J; Guo, Y Semisynthesis, biological activities, and mechanism studies of Mannich base analogues of magnolol/honokiol as potential α-glucosidase inhibitors. Bioorg Med Chem 75: (2022)